SIRT4 and B-cell non-Hodgkin lymphoma: The positive expression of SIRT4 in B-cell lymphoma downregulates glutamine uptake and inhibits cell growth, whereas deletion of SIRT4 in the Eμ-myc models up-regulates glutamine consumption and accelerates tumorigenesis [162].